Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sitagliptin (januvia) (1 trial)
Diabetes Mellitus, Type 2 (Phase 2)
Fibromyalgia (Phase 2)
Mitochondrial Diseases (Phase 2)
Movement Disorders (Phase 2)
Myofascial Pain Syndromes (Phase 2)
Trials (1 total)
Trial APIs (1 total)